Respules Spray

Nasal and Respiratory Sprays — Saturn Formulations PCD Pharma Franchise

Nasal and respiratory spray formulations deliver medication directly to the site of disease — the nasal mucosa, bronchial epithelium, and upper airway — achieving high local drug concentrations with minimal systemic absorption and adverse effects. This targeted delivery advantage makes sprays the preferred therapy for allergic rhinitis, nasal polyps, sinusitis, bronchial asthma, and COPD — conditions that together affect over 100 million Indians. Saturn Formulations, a WHO-GMP and ISO-certified pharmaceutical manufacturer established in 2012, offers a comprehensive range of Nasal and Respiratory Sprays including intranasal corticosteroids, decongestant nasal sprays, saline irrigation solutions, antihistamine nasal sprays, and bronchodilator metered-dose inhalers — providing PCD Pharma Franchise partners with a complete upper and lower respiratory aerosol therapy portfolio.

Why Choose Saturn Formulations for Respiratory Spray Franchise?

• Allergic Rhinitis Epidemic: Estimated 20–30% of India's urban population has allergic rhinitis — creating massive demand for nasal corticosteroid sprays.
• Specialist and GP Prescribing: ENT surgeons, pulmonologists, allergists, and general practitioners all prescribe nasal and respiratory sprays — maximising prescriber reach.
• OTC and Prescription Dual Market: Saline nasal sprays and decongestant sprays are purchased OTC while corticosteroid nasal sprays are prescription-driven — two complementary revenue streams.
• High Patient Compliance: Once-daily nasal spray administration is the most convenient topical respiratory therapy — driving patient adherence and repeat prescribing.
• WHO-GMP Compliant Aerosol Manufacturing: Pharmaceutical-grade spray and aerosol production with validated dose delivery and particle size testing.
• Monopoly Territory Rights: Exclusive ENT/respiratory franchise territory assignment.

Our Nasal and Respiratory Spray Range

Intranasal Corticosteroid Sprays

Fluticasone Propionate 50mcg/actuation aqueous nasal spray — the gold standard intranasal corticosteroid for allergic rhinitis, delivering superior anti-inflammatory mucosal control with minimal systemic bioavailability (<1%). Mometasone Furoate 50mcg/actuation nasal spray for allergic and non-allergic rhinitis with once-daily dosing convenience. Beclomethasone Dipropionate 50mcg nasal spray for nasal polyp management and chronic rhinosinusitis. Budesonide 64mcg/actuation nasal spray for seasonal and perennial allergic rhinitis — available in 120-dose metered-dose pump bottles.

Decongestant Nasal Sprays

Oxymetazoline Hydrochloride 0.025% (paediatric) and 0.05% (adult) nasal spray for acute nasal congestion relief — the most widely purchased OTC nasal spray in India. Xylometazoline 0.05% and 0.1% nasal spray for 8–10 hour nasal decongestion. These decongestant sprays drive high pharmacy counter sales and complement prescription corticosteroid sprays for acute allergic rhinitis episodes.

Antihistamine and Combination Nasal Sprays

Azelastine 0.1% nasal spray for allergic rhinitis — fast-onset (15-minute) antihistamine nasal spray preferred for acute allergy episodes. Fluticasone + Azelastine combination nasal spray (Dymista-equivalent) for moderate-to-severe allergic rhinitis requiring both anti-inflammatory and antihistamine control — a high-value specialist product with the clinical evidence to support premium pricing.

Saline and Hypertonic Nasal Sprays and Rinses

Isotonic Sodium Chloride 0.9% preservative-free nasal spray for nasal hygiene, post-operative nasal care, and sinus humidification. Hypertonic Saline 2.3% and 3% nasal spray for mucociliary clearance enhancement in chronic rhinosinusitis, cystic fibrosis, and post-nasal drip. High-volume nasal irrigation kit (Neti pot equivalent) with hypertonic buffered saline for ENT surgeon-recommended nasal sinus irrigation. These products have strong pharmacist recommendation and patient repurchase rates.

Bronchodilator Metered-Dose Inhalers (MDIs)

Salbutamol 100mcg/actuation MDI (200 doses) — the essential rescue bronchodilator for asthma and COPD, present in every asthma patient's treatment protocol. Ipratropium 20mcg MDI for COPD maintenance bronchodilation. Formoterol 12mcg MDI for long-acting bronchodilator (LABA) maintenance therapy. Beclomethasone 100mcg MDI for inhaled corticosteroid asthma control. MDI production requires specialised pressurised container manufacturing equipment — our certified facility delivers consistent dose uniformity across all actuations.

Quality Standards — Spray and Aerosol Manufacturing

Nasal spray pumps are tested for dose delivery per actuation (DPA), spray pattern, droplet size distribution (laser diffraction), and priming/re-priming performance per IP/BP/USP aerosol testing standards. Aqueous nasal spray formulations undergo pH optimisation (pH 6.0–7.0 for nasal compatibility), osmolality measurement, preservative efficacy testing, and microbial limit testing per pharmacopoeial requirements. MDI production involves validated propellant filling under pressure, valve crimping integrity testing, dose content uniformity testing per BP/USP, and spray pattern and plume geometry characterisation. Each batch of nasal spray and MDI is tested for number of actuations to determine canister fill adequacy.

Start Your Respiratory Spray Franchise

1. Contact us: +91-8729000609 | enquiry.saturn@gmail.com
2. Select nasal/respiratory spray SKUs from our catalogue
3. Submit Drug License and GST documents
4. Confirm ENT/respiratory specialist territory
5. Receive products and ENT/pulmonology promotional materials

Saturn Formulations' Nasal and Respiratory Spray franchise positions you at the centre of India's rapidly growing allergic and respiratory disease management market. Call: +91-8729000609.